Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | +0.61% | +2.40% | +33.26% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 376M | Sales 2025 * | 445M | Capitalization | 2.35B |
---|---|---|---|---|---|
Net income 2024 * | 38M | Net income 2025 * | 51M | EV / Sales 2024 * | 5.47 x |
Net cash position 2024 * | 298M | Net cash position 2025 * | 426M | EV / Sales 2025 * | 4.33 x |
P/E ratio 2024 * |
72
x | P/E ratio 2025 * |
48.3
x | Employees | 1,008 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.13% |
Latest transcript on Cellebrite DI Ltd.
1 day | +0.61% | ||
1 week | +4.25% | ||
Current month | +6.75% | ||
1 month | +11.18% | ||
3 months | +7.45% | ||
6 months | +44.25% | ||
Current year | +33.26% |
Managers | Title | Age | Since |
---|---|---|---|
Yossi Carmil
CEO | Chief Executive Officer | 57 | 03-12-31 |
Dana Gerner
DFI | Director of Finance/CFO | 56 | 14-05-06 |
Ayala Shapira
CMP | Compliance Officer | 53 | 22-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Clammer
BRD | Director/Board Member | 53 | 21-08-29 |
Thomas Hogan
CHM | Chairman | 64 | 23-08-07 |
Dafna Gruber
BRD | Director/Board Member | 58 | 21-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +6.24% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 11.54 | +0.61% | 677,978 |
24-05-15 | 11.47 | +1.50% | 1,207,628 |
24-05-14 | 11.3 | +1.35% | 622,403 |
24-05-13 | 11.15 | +0.90% | 513,413 |
24-05-10 | 11.05 | -1.95% | 554,607 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.26% | 2.35B | |
+11.94% | 3,144B | |
+10.56% | 88.51B | |
+6.08% | 79.76B | |
-14.73% | 54.56B | |
+26.21% | 48.26B | |
-23.40% | 47.95B | |
+29.50% | 44.14B | |
+76.40% | 39.42B | |
-9.24% | 25.26B |
- Stock Market
- Equities
- CLBT Stock